Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rikke Kølby Christensen is active.

Publication


Featured researches published by Rikke Kølby Christensen.


Cancer Cytopathology | 2013

Evaluation of p16INK4a/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion

Marianne Waldstrøm; Rikke Kølby Christensen; Dorthe Ørnskov

The objective of the current study was to investigate the clinical performance of detecting high‐grade lesions with the CINtec PLUS p16INK4a/Ki‐67 dual stain and the APTIMA human papillomavirus (HPV) Assay in a cohort of women with low‐grade squamous intraepithelial lesion (LSIL) cytology. The authors also assessed the reproducibility of the evaluation of immunocytochemical staining.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2009

Value of fine-needle aspiration biopsy of salivary gland lesions

Rikke Kølby Christensen; Kristine Bjørndal; Christian Godballe; Annelise Krogdahl

The aim of this study was to assess the utility of fine‐needle aspiration biopsy (FNAB) in the diagnosis and treatment planning of the lesions of the salivary gland.


Regenerative Medicine | 2008

Transformation of human mesenchymal stem cells in radiation carcinogenesis: long-term effect of ionizing radiation

Rikke Kølby Christensen; Jan Alsner; Flemming Brandt Sørensen; Frederik Dagnæs-Hansen; Steen Kølvraa; Nedime Serakinci

Increasing evidence on cancer stem cells suggest that stem cells are susceptive to carcinogenesis and consequently can be the origin of many cancers. We have recently established a telomerase-transduced human mesenchymal stem cell line and subsequently irradiated this in order to achieve malignant transformation. In the present study, we analyzed the long-term effect of ionizing radiation on these cells and investigate whether radiation can trigger tumor development. The cells were irradiated with a low (2.5 Gy) and a high (15 Gy) dose of gamma-rays and followed for up to 6 months after radiation. A subclone of the cells irradiated with 2.5 Gy of gamma-rays formed tumors after implantation to severe combined immunodeficiency mice. During the process of transformation, the cells showed accelerated telomere shortening, increased levels of anaphase bridges and a shift from balanced to unbalanced translocations. The tumor suppressor genes p53 and p21(CIP1) functioned normally throughout the study. Our observations indicate that radiation destabilized the telomeres and that the presence of uncapped telomeres initiated fusion-break-fusion cycles, resulting in increased chromosomal instability and tumor formation. Thus, bone marrow-derived human mesenchymal stem cells are capable of exhibiting a malignant phenotype.


BMC Cancer | 2010

Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer

Karina Dahl Steffensen; Marianne Waldstrøm; Rikke Kølby Christensen; Annette Bartels; Nils Brünner; Anders Jakobsen

BackgroundTissue inhibitor of metalloproteinase 1 (TIMP-1) is a natural inhibitor of the matrix metalloproteinases (MMPs) which are proteolytic enzymes involved in degradation of extracellular matrix thereby favoring tumour cell invasion and metastasis. TIMP-1 activity in tumour tissue may therefore play an essential role in the progression of a malignant tumour.The primary aim of the present study was to evaluate TIMP-1 protein immunoreactivity in tissue from primary ovarian cancer patients and associate these findings with the course of the disease including response to treatment in the individual patient.MethodsTIMP-1 was assessed by immunohistochemistry (in tissue micro arrays) in a total of 163 ovarian cancer specimens obtained from primary debulking surgery during 1991-1994 as part of a randomized clinical protocol.ResultsPositive TIMP-1 immunoreactivity was found in 12.3% of the tumours. The median survival time for the 143 patients with TIMP-1 negative tumours was 23.7 months [19.0-29.4] 95% CI, while the median survival time for the 20 patients with TIMP-1 positive tumours was 15.9 months [12.3-27.4] 95% CI. Although a difference of 7.8 months in median overall survival in favor of the TIMP-1 tumour negative patients was found, this difference did not reach statistical significance (p = 0.28, Kaplan-Meier, log-rank test). Moreover, TIMP-1 immunoreactivity was not associated with CA125 response (p = 0.53) or response at second look surgery (p = 0.72).ConclusionTIMP-1 immunoreactivity in tumour tissue from patients with primary epithelial ovarian cancer did not correlate with patient survival or response to combination platinum/cyclophosphamide therapy.


Cancer Cytopathology | 2013

Evaluation of p16INK4a/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion: p16INK4a/Ki-67 Dual Staining in LSIL

Marianne Waldstrøm; Rikke Kølby Christensen; Dorthe Ørnskov

The objective of the current study was to investigate the clinical performance of detecting high‐grade lesions with the CINtec PLUS p16INK4a/Ki‐67 dual stain and the APTIMA human papillomavirus (HPV) Assay in a cohort of women with low‐grade squamous intraepithelial lesion (LSIL) cytology. The authors also assessed the reproducibility of the evaluation of immunocytochemical staining.


Cancer Cytopathology | 2013

Evaluation of p16INK4a/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion: Cancer Cytopathology

Marianne Waldstrøm; Rikke Kølby Christensen; Dorthe Ørnskov

The objective of the current study was to investigate the clinical performance of detecting high‐grade lesions with the CINtec PLUS p16INK4a/Ki‐67 dual stain and the APTIMA human papillomavirus (HPV) Assay in a cohort of women with low‐grade squamous intraepithelial lesion (LSIL) cytology. The authors also assessed the reproducibility of the evaluation of immunocytochemical staining.


Archive | 2011

Transformation of Mesenchymal Stem Cells

Nedime Serakinci; Rikke Kølby Christensen; Umut Fahrioglu

As part of normal organismal homeostasis, the human body loses various types of cells like hepatocytes, keratinocytes and certain types of blood cells and needs to replace them. These cells are replaced using stem cells as the source. Many different names are used for cells with stem cell-like properties, such as precursor cells, progenitor cells, somatic stem cells and adult stem cells. Stem cells are unique cells that have the ability to renew themselves through mitotic cell division and differentiate into a diverse range of specialized cell types. In addition, stem cells, with few notable exceptions, are cell types that show telomerase activity and therefore, actively maintain telomere length to some degree. The ability to maintain telomere length allows them to have an extended proliferative capacity compared to somatic cells. There are three kinds of stem cells: Embryonic, germinal and somatic or in other terms adult stem cells. The differentiation potential of stem cells varies according to type from totipotency to unipotency. Cells such as the fertilized oocytes, up to the 8-cell blastocyst, are considered to be totipotent since they can differentiate and generate a complete organism. Embryonic stem (ES) cells are derived from the inner cell mass of a blastocyst. ES cells posses all the characteristics of true stem cells. In addition to the self-renewal capacity, they are pluripotent, being able to produce derivates of all three germ layers (endoderm, mesoderm and ectoderm) but not the complete organism (Burdon et al., 2002). A high telomerase activity prevents the ES cells from undergoing crisis and reaching senescence, which is an advantage for long-term culturing. ES cells have furthermore been shown to retain their developmental identity even after reintroduction into the blastocyst (Beddington & Robertson, 1989). Somatic stem cells are differentiated forms of embryonic stem cells that are known as multipotent stem cells. They are capable of self-renewal and are responsible for the regenerative property of the e.g. hematopoietic system and the gastrointestinal system. These cells can be isolated from the developing organism (the fetus and the postnatal organism) as well as from the adult organism. Depending on their origin, the offspring of the somatic stem cells is also specific to the original tissue. A stem cell is said to be unipotent like the epidermal stem cells if they can persistently give rise to only a specific cell type. It has for many years been known that stem cells – contrary to other cell types –


Cancer Biotherapy and Radiopharmaceuticals | 2011

Mesenchymal Stem Cells as Therapeutic Delivery Vehicles Targeting Tumor Stroma

Nedime Serakinci; Rikke Kølby Christensen; Umut Fahrioglu; Flemming Brandt Sørensen; Frederik Dagnæs-Hansen; Miroslav Hajek; Tinna Herløv Jensen; Steen Kølvraa; Nicol W. Keith


Journal of Oral Pathology & Medicine | 2007

Sentinel lymph nodes in cancer of the oral cavity: is central step-sectioning enough?

Jørn Bo Thomsen; Rikke Kølby Christensen; Jens Ahm Sørensen; Annelise Krogdahl


Archive | 2015

Adult Stem Cells

Rikke Kølby Christensen; Nedime Serakinci

Collaboration


Dive into the Rikke Kølby Christensen's collaboration.

Top Co-Authors

Avatar

Marianne Waldstrøm

University of Southern Denmark

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Steen Kølvraa

University of Southern Denmark

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Annelise Krogdahl

Odense University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Celia Ferese

National University of La Plata

View shared research outputs
Top Co-Authors

Avatar

César L.A. Gómez Dumm

National University of La Plata

View shared research outputs
Researchain Logo
Decentralizing Knowledge